Stefaan W Van Gool Selected Research

Stefaan W Van Gool Research Topics

Disease

27	Neoplasms (Cancer) 01/2024 - 05/2004
16	Glioma (Gliomas) 11/2017 - 05/2004
12	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 09/2007
2	Uterine Neoplasms (Uterine Cancer) 01/2014 - 09/2010
2	Ovarian Neoplasms (Ovarian Cancer) 12/2013 - 09/2013
2	Carcinoma (Carcinomatosis) 09/2013 - 12/2008
1	Choroid Plexus Carcinoma 02/2022
1	Choroid Plexus Papilloma 02/2022
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 02/2022
1	Diffuse Intrinsic Pontine Glioma 05/2020
1	Circulating Neoplastic Cells 05/2020
1	Hyperthermia 05/2020
1	Central Nervous System Neoplasms 04/2016
1	Demyelinating Diseases (Demyelinating Disease) 06/2015
1	Inflammation (Inflammations) 06/2015
1	Infections 03/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Carcinosarcoma 09/2013
1	Brain Neoplasms (Brain Tumor) 04/2011
1	Endometrial Neoplasms (Endometrial Cancer) 09/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2009
1	Carcinogenesis 12/2008
1	Endometrioid Carcinoma 12/2008
1	Sarcoma (Soft Tissue Sarcoma) 12/2008
1	Edema (Dropsy) 05/2008

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 01/2024 - 05/2008
5	Galectin 1 (LGALS1)IBA 01/2017 - 04/2011
3	Messenger RNA (mRNA)IBA 05/2020 - 09/2010
3	Proteins (Proteins, Gene)FDA Link 02/2016 - 04/2005
3	AntigensIBA 03/2015 - 04/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2014 - 09/2007
2	SuspensionsIBA 11/2017 - 04/2016
2	Temozolomide (Temodar)FDA LinkGeneric 10/2017 - 01/2017
2	CytokinesIBA 06/2015 - 09/2007
2	InterleukinsIBA 07/2014 - 09/2007
2	Carrier Proteins (Binding Protein)IBA 02/2014 - 04/2011
2	Polysaccharides (Glycans)IBA 02/2014 - 04/2011
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	dipinacoline glutamateIBA 05/2020
1	Immune Checkpoint ProteinsIBA 11/2017
1	Blocking AntibodiesIBA 11/2017
1	Galectins (Galectin)IBA 04/2016
1	Small Interfering RNA (siRNA)IBA 04/2016
1	ChitosanIBA 04/2016
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016
1	AntioxidantsIBA 02/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2016
1	SolutionsIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 06/2015
1	CalreticulinIBA 03/2015
1	HMGB1 Protein (HMG1)IBA 03/2015
1	Therapeutic UsesIBA 03/2015
1	Immune Checkpoint InhibitorsIBA 01/2015
1	Polytetrafluoroethylene (Teflon)FDA Link 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2014
1	MicroRNAs (MicroRNA)IBA 02/2014
1	RNA (Ribonucleic Acid)IBA 10/2009
1	Cancer VaccinesIBA 06/2009
1	Transcription Factors (Transcription Factor)IBA 12/2008
1	ParaffinIBA 12/2008
1	Interleukin-10 (Interleukin 10)IBA 09/2007
1	InterferonsIBA 09/2007
1	Interferon-gamma (Interferon, gamma)IBA 09/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2006
1	Fluorescein-5-isothiocyanate (FITC)IBA 04/2005

Therapy/Procedure

24	Immunotherapy 01/2021 - 01/2005
9	Therapeutics 01/2021 - 05/2004
2	Drug Therapy (Chemotherapy) 02/2022 - 05/2020
2	Chemoradiotherapy 01/2021 - 11/2012
1	Precision Medicine 07/2020
1	Molecular Targeted Therapy 05/2020
1	Intranasal Administration 04/2016
1	Oncolytic Virotherapy 01/2015
1	Combined Modality Therapy 04/2011
1	Injections 09/2010
1	Radiotherapy 05/2004